Literature DB >> 33707412

CSF3R T618I mutant chronic myelomonocytic leukemia (CMML) defines a proliferative CMML subtype enriched in ASXL1 mutations with adverse outcomes.

Evandro D Bezerra1, Terra L Lasho1, Christy M Finke1, Antoine N Saliba1, Michelle A Elliott1, Animesh D Pardanani1, Naseema Gangat1, Abhishek A Mangaonkar1, Rhett P Ketterling2, Ayalew Tefferi1, Eric Solary3,4, Mrinal M Patnaik5.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2021        PMID： 33707412      PMCID： PMC7952717          DOI： 10.1038/s41408-021-00449-9

Source DB:  PubMed          Journal:  Blood Cancer J        ISSN： 2044-5385            Impact factor:   11.037


× No keyword cloud information.
  13 in total

Review 1.  Chronic neutrophilic leukemia: 2020 update on diagnosis, molecular genetics, prognosis, and management.

Authors:  Natasha Szuber; Michelle Elliott; Ayalew Tefferi
Journal:  Am J Hematol       Date:  2019-12-30       Impact factor: 10.047

2.  Mutation of the colony-stimulating factor-3 receptor gene is a rare event with poor prognosis in chronic myelomonocytic leukemia.

Authors:  O Kosmider; R Itzykson; V Chesnais; T Lasho; R Laborde; R Knudson; A Gauthier; J Merlevede; L Ades; M Morabito; M Fontenay; A Tefferi; N Droin; E Solary
Journal:  Leukemia       Date:  2013-06-18       Impact factor: 11.528

Review 3.  The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia.

Authors:  Daniel A Arber; Attilio Orazi; Robert Hasserjian; Jürgen Thiele; Michael J Borowitz; Michelle M Le Beau; Clara D Bloomfield; Mario Cazzola; James W Vardiman
Journal:  Blood       Date:  2016-04-11       Impact factor: 22.113

4.  CSF3R T618I is a highly prevalent and specific mutation in chronic neutrophilic leukemia.

Authors:  A Pardanani; T L Lasho; R R Laborde; M Elliott; C A Hanson; R A Knudson; R P Ketterling; J E Maxson; J W Tyner; A Tefferi
Journal:  Leukemia       Date:  2013-04-22       Impact factor: 11.528

5.  Prognostic score including gene mutations in chronic myelomonocytic leukemia.

Authors:  Raphaël Itzykson; Olivier Kosmider; Aline Renneville; Véronique Gelsi-Boyer; Manja Meggendorfer; Margot Morabito; Céline Berthon; Lionel Adès; Pierre Fenaux; Odile Beyne-Rauzy; Norbert Vey; Thorsten Braun; Torsten Haferlach; François Dreyfus; Nicholas C P Cross; Claude Preudhomme; Olivier A Bernard; Michaela Fontenay; William Vainchenker; Susanne Schnittger; Daniel Birnbaum; Nathalie Droin; Eric Solary
Journal:  J Clin Oncol       Date:  2013-05-20       Impact factor: 44.544

6.  Oncogenic CSF3R mutations in chronic neutrophilic leukemia and atypical CML.

Authors:  Julia E Maxson; Jason Gotlib; Daniel A Pollyea; Angela G Fleischman; Anupriya Agarwal; Christopher A Eide; Daniel Bottomly; Beth Wilmot; Shannon K McWeeney; Cristina E Tognon; J Blake Pond; Robert H Collins; Basem Goueli; Stephen T Oh; Michael W Deininger; Bill H Chang; Marc M Loriaux; Brian J Druker; Jeffrey W Tyner
Journal:  N Engl J Med       Date:  2013-05-09       Impact factor: 91.245

7.  Clinical significance of CSF3R, SRSF2 and SETBP1 mutations in chronic neutrophilic leukemia and chronic myelomonocytic leukemia.

Authors:  Yuan Ouyang; Chun Qiao; Yu Chen; Su-Jiang Zhang
Journal:  Oncotarget       Date:  2017-03-28

8.  CSF3R-mutated chronic neutrophilic leukemia: long-term outcome in 19 consecutive patients and risk model for survival.

Authors:  Natasha Szuber; Christy M Finke; Terra L Lasho; Michelle A Elliott; Curtis A Hanson; Animesh Pardanani; Ayalew Tefferi
Journal:  Blood Cancer J       Date:  2018-02-15       Impact factor: 11.037

9.  An activating mutation in the CSF3R gene induces a hereditary chronic neutrophilia.

Authors:  Isabelle Plo; Yanyan Zhang; Jean-Pierre Le Couédic; Mayuka Nakatake; Jean-Michel Boulet; Miki Itaya; Steven O Smith; Najet Debili; Stefan N Constantinescu; William Vainchenker; Fawzia Louache; Stéphane de Botton
Journal:  J Exp Med       Date:  2009-07-20       Impact factor: 14.307

10.  Clinical, molecular, and prognostic correlates of number, type, and functional localization of TET2 mutations in chronic myelomonocytic leukemia (CMML)-a study of 1084 patients.

Authors:  Giacomo Coltro; Abhishek A Mangaonkar; Terra L Lasho; Christy M Finke; Prateek Pophali; Ryan Carr; Naseema Gangat; Moritz Binder; Animesh Pardanani; Martin Fernandez-Zapico; Keith D Robertson; Alberto Bosi; Nathalie Droin; Alessandro M Vannucchi; Ayalew Tefferi; Anthony Hunter; Eric Padron; Eric Solary; Mrinal M Patnaik
Journal:  Leukemia       Date:  2019-12-13       Impact factor: 11.528
View more
  2 in total

1.  CSF3R T618I mutant myelodysplastic/myeloproliferative neoplasm in the elderly: An age-related disease with unfavorable prognosis.

Authors:  Xinmin Zhang; Cristina Ghiuzeli; Erin Jou; Peihong Hsu; Jonathan Kolitz; Judith P Brody
Journal:  Leuk Res Rep       Date:  2022-06-25

2.  CSF3R T618I mutated chronic myelomonocytic leukemia: A proliferative subtype with a distinct mutational profile.

Authors:  Adelaide Kwon; Ibrahim Ibrahim; Tri Le; Jesse Manuel Jaso; Olga Weinberg; Franklin Fuda; Weina Chen
Journal:  Leuk Res Rep       Date:  2022-05-06
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.